← Leaderboards
John Gillespie
20/20 Genesystems, Inc.
$1,179,989
Attributed
$1,179,989
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $980.4K · FY2010–12$1M$750K$500K$250K$0
'10
'11
'12
Funding mix
By agency
NIH$1,179,989 · 2
By mechanism
R44$980,392 · 1
N43$199,597 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Renal Carcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$97,125,175
- Ian M Thompson · University Of Texas Hlth Sci Ctr San Ant$23,354,043
- John James McNeil · Hennepin Healthcare Research Institute$22,201,424
- John H Sampson · Duke University$19,179,772
- William G Kaelin · Dana-Farber Cancer Institute$18,573,699
- Richard H Grimm · University Of Minnesota Twin Cities$17,709,591
Research focus
Renal CarcinomaDiagnosticPharmaceutical PreparationsTherapeutic AgentsMarketingCompanionsDiagnostic TestsMedicineReproducibilityTumorProgramsBusinessesInnovationCancer TypeCancer TherapyBaseBreast Cancer TreatmentAwardAlgorithmsCollaborationsCohortBody FluidsCollegeClinical Trials